CORRECTION FROM SOURCE: Wellgistics Health Releases Letter to Our Shareholders
This Press Release updates the information from the previous release.Why Vertical Integration and Blockchain Will Define the Next Era of Healthcare TAMPA, FL / ACCESS Newswire / May 21, 2026 / Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), …
This Press Release updates the information from the previous release.
Why Vertical Integration and Blockchain Will Define the Next Era of Healthcare
TAMPA, FL / ACCESS Newswire / May 21, 2026 / Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a health information technology leader, integrating proprietary pharmacy dispensing optimization artificial intelligence (AI) platform EinsteinRx into its patented blockchain-enabled smart contracts platform PharmacyChain, today released a letter to shareholders expanding upon the strategy behind recently announced transactions.
'Dear Fellow Shareholders,
Yesterday we announced a series of transactions that, taken together, mark the most consequential strategic moment in Wellgistics Health's history. We are writing today to explain what connects them - and why we believe the steps we are taking now will position Wellgistics as essential infrastructure for the healthcare industry of the next decade.
Our thesis is straightforward: vertical integration is the only path to real efficiency in healthcare, and blockchain is the only architecture capable of supporting it at scale. Every participant in healthcare - providers, payors, pharmacies, manufacturers, and patients - is operating with fragmented data, duplicated workflows, and trust gaps that cost the system hundreds of billions of dollars each year. We believe these inefficiencies cannot be solved by another point solution layered on top of legacy systems. They require a unified data fabric that captures, verifies, and exchanges health information across every node of care. That fabric will be built on blockchain. We believe it is not a question of whether the industry adopts blockchain-based infrastructure, but when - and who is positioned to provide it.
That conviction is the strategic logic behind every announcement we made yesterday.
DelivMeds AI and the expanded Datavault license give us the enabling intellectual property for commercial tokenized healthcare data management. Tokenization is the mechanism that turns fragmented health data into a verifiable, exchangeable, and valuable asset. By forming DelivMeds AI and consolidating these capabilities inside our EinsteinRx platform, we are building the data layer that the rest of the industry will eventually need to plug into.

